Chinese General Practice ›› 2019, Vol. 22 ›› Issue (31): 3850-3856.DOI: 10.12114/j.issn.1007-9572.2019.00.589
Special Issue: 高血压最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2019-11-05
Online:
2019-11-05
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.589
[1]KEARNEY P M,WHELTON M,REYNOLDS K,et al.Global burden of hypertension:analysis of worldwide data[J].Lancet,2005,365(9455):217-223.DOI:10.1016/s0140-6736(05)17741-1. [2]MILLS K T,BUNDY J D,KELLY T N,et al.Global disparities of hypertension prevalence and control:a systematic analysis of population-based studies from 90 countries[J].Circulation,2016,134(6):441-450.DOI:10.1161/circulationaha.115.018912. [3]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.DOI:10.3969/j.issn.1000-3614.2019.03.001. HU S S,GAO R L,LIU L S,et al.Summary of the 2018 report on cardiovascular diseases in China[J].Chinese Circulation Journal,2019,34(3):209-220.DOI:10.3969/j.issn.1000-3614.2019.03.001. [4]DORES H,SANTOS P,SALVADOR F,et al.Blood pressure in young adults[J].Rev Port Cardiol,2010,29(10):1495-1508.DOI:10.1016/S0300-8932(10)70260-8. [5]全国血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991年抽样调查结果[J].高血压杂志,1995,3(s1):16-20. National Blood Pressure Sampling Survey Collaborative Group.Hypertension prevalence and the status of people awareness,treatment,and control in China:a national-wide survey in 1991[J].Chinese Journal of Hypertension,1995,3(s1):16-20. [6]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484.DOI:10.3760/j.issn:0254-6450.2005.07.004. LI L M,RAO K Q,KONG L Z,et al.A description on the Chinese national nutrition and health survey in 2002[J].Chinese Journal of Epidemiology,2005,26(7):478-484.DOI:10.3760/j.issn:0254-6450.2005.07.004. [7]CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.Seventh report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure[J].Hypertension,2003,42(6):1206-1252.DOI:10.1161/01.HYP.0000107251.49515.c2. [8]中国高血压防治指南修订委员会,高血压联盟中华医学会心血管病学分会,中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.DOI:10.3969/j.issn.1007-5410.2019.01.002. Writing Group of 2018 Chinese Guidelines for the Management of Hypertension,Hypertension Alliance of Chinese Medical Association Cardiovascular Disease Branch,Chinese Medical Association Hypertension Professional Committee,et al.Chinese guidelines for the prevention and treatment of hypertension(2018)[J].Chin J Cardiovasc,2019,24(1):24-56.DOI:10.3969/j.issn.1007-5410.2019.01.002. [9]青年[EB/OL].[2018-11-12].http://baike.baidu.com.item/%E9%9D%92%E5%B9%B41/398408. [10]EPSTEIN L J,KRISTO D,STROLLO P J JR,et al.Clinical guideline for the evaluation,management and long-term care of obstructive sleep apnea in adults[J].J Clin Sleep Med,2009,5(3):263-276. [11]中国医师协会睡眠医学专业委员会.成人阻塞性睡眠呼吸暂停多学科诊疗指南[J].中华医学杂志,2018,98(24):1902-1914.DOI:10.3760/cma.j.issn.0376-2491.2018.24.003.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201824003. [12]中国医疗保健国际交流促进会血管疾病高血压分会专家共识起草组.肾动脉狭窄的诊断和处理中国专家共识[J].中国循环杂志,2017,32(9):835-844.DOI:10.3969/j.issn.1000-3614.2017.09.002.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxhzz201709002. [13]中华医学会风湿病学分会.大动脉炎诊断及治疗指南[J].中华风湿病学杂志,2011,15(2):119-120.DOI:10.3760/cma.j.issn.1007-7480.2011.02.013.http://www.doc88.com/p-0071982146143.html. [14]PERSU A,GIAVARINI A,TOUZE E,et al.European consensus on the diagnosis and management of fibromuscular dysplasia[J].J Hypertens,2014,32(7):1367-1378.DOI:10.1097/hjh.0000000000000213. [15]中华医学会内分泌学分会肾上腺学组.原发性醛固酮增多症诊断治疗的专家共识[J].中华内分泌代谢杂志,2016,32(3):188-195.DOI:10.3760/cma.j.issn.1000-6699.2016.03.003.http://d.old.wanfangdata.com.cn/Periodical/zhnfmdx201603003. [16]SONG Y,YANG S,HE W,et al.Confirmatory tests for the diagnosis of primary aldosteronism:a prospective diagnostic accuracy study[J].Hypertension,2018,71(1):118-124.DOI:10.1161/hypertensionaha.117.10197. [17]中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志,2018,53(1):2-6.DOI:10.3760/cma.j.issn.0529-567x.2018.01.002.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfck201801002. [18]中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志,2016,32(3):181-187.DOI:10.3760/cma.j.issn.1000-6699.2016.03.002.http://d.old.wanfangdata.com.cn/Periodical/zhnfmdx201603002. [19]中国垂体腺瘤协作组.中国库欣病诊治专家共识(2015)[J].中华医学杂志,2016,96(11):835-840.DOI:10.3760/cma.j.issn.0376-2491.2016.11.002.http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhyx201611002. [20]WILLIAMS B,MANCIA G,SPIERING W,et al.2018 ESC/ESH guidelines for the management of arterial hypertension[J].Eur Heart J,2018,39(33):3021-3104.DOI:10.1093/eurheartj/ehy339. [21]王志华,初少莉,陈绍行,等.高血压住院患者病因及危险因素分析[J].高血压杂志,2005,13(8):504-509.DOI:10.3969/j.issn.1673-7245.2005.08.017. WANG Z H,CHU S L,CHEN S X,et al.Analysis of etiology and risk factors of in-patients with hypertension[J].Chin J Hypertension,2005,13(8):504-509.DOI:10.3969/j.issn.1673-7245.2005.08.017. [22]DANIELSON M,DAMMSTROM B.The prevalence of secondary and curable hypertension[J].Acta Med Scand,1981,209(6):451-455.DOI:10.1111/j.0954-6820.1981.tb11628.x. [23]ANDERSON G H JR,BLAKEMAN N,STREETEN D H.The effect of age on prevalence of secondary forms of hypertension in 4 429 consecutively referred patients[J].J Hypertens,1994,12(5):609-615. [24]OMURA M,SAITO J,YAMAGUCHI K,et al.Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan[J].Hypertens Research,2004,27(3):193-202. [25]FLORCZAK E,PREJBISZ A,SZWENCH-PIETRASZ E,et al.Clinical characteristics of patients with resistant hypertension:the RESIST-POL study[J].J Hum Hypertens,2013,27(11):678-685.DOI:10.1038/jhh.2013.32. [26]WANG L,LI N,YAO X,et al.Detection of secondary causes and coexisting diseases in hypertensive patients:OSA and PA are the common causes associated with hypertension[J].Biomed Res Int,2017(6):1-8.DOI:10.1155/2017/8295010. [27]CHARLES L,TRISCOTT J,DOBBS B.Secondary hypertension:discovering the underlying cause[J].Am Fam Physician,2017,96(7):453-461. [28]NOILHAN C,BARIGOU M,BIELER L,et al.Causes of secondary hypertension in the young population:a monocentric study[J].Ann Cardiol Angeiol(Paris),2016,65(3):159-164.DOI:10.1016/j.ancard.2016.04.016. [29]RUDNICK K V,SACKETT D L,HIRST S,et al.Hypertension in a family practice[J].Can Med Assoc J,1977,117(5):492-497.DOI:10.1016/0091-7435(79)90041-0. [30]STREETEN D H,ANDERSON G H,ELIAS M F.Prevalence of secondary hypertension and unusual aspects of the treatment of hypertension in elderly individuals[J].Geriatr Nephrol Urol,1992,2(2):91-98.DOI:10.1007/BF00451671. [31]ARAR M Y,HOGG R J,ARANT B S JR,et al.Etiology of sustained hypertension in children in the southwestern United States[J].Pediatr Nephrol,1994,8(2):186-189.DOI:10.1007/BF00865475. [32]HAAS D C,FOSTER G L,NIETO F J,et al.Age-dependent associations between sleep-disordered breathing and hypertension:importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the sleep heart health study[J].Circulation,2005,111(5):614-621.DOI:10.1161/01.cir.0000154540.62381.cf. [33]CHAHAL C A,SOMERS V K.Secondary hypertension:obstructive sleep apnea[J].J Am Soc Hypertens,2015,9(3):244-247.DOI:10.1016/j.jash.2015.02.001. [34]PEPPARD P E,YOUNG T,PALTA M,et al.Prospective study of the association between sleep-disordered breathing and hypertension[J].N Engl J Med,2000,342(19):1378-1384.DOI:10.1056/nejm200005113421901. [35]MARIN J M,AGUSTI A,VILLAR I,et al.Association between treated and untreated obstructive sleep apnea and risk of hypertension[J].JAMA,2012,307(20):2169-2176.DOI:10.1001/jama.2012.3418. [36]LANTELME P,HARBAOUI B,COURAND P Y.Renal artery stenosis[J].Rev Prat,2015,65(6):822-826. [37]PENG M,JIANG X J,DONG H,et al.Etiology of renal artery stenosis in 2 047 patients:a single-center retrospective analysis during a 15-year period in China[J].J Hum Hypertens,2016,30(2):124-128.DOI:10.1038/jhh.2015.40. [38]CONN J W.Primary aldosteronism[J].J Lab Clin Med,1955,45(4):661-664. [39]PIADITIS G,MARKOU A,PAPANASTASIOU L,et al.Progress in aldosteronism:a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension[J].Eur J Endocrinol,2015,172(5):R191-203.DOI:10.1530/eje-14-0537. [40]FUNDER J W,CAREY R M,MANTERO F,et al.The management of primary aldosteronism:case detection,diagnosis,and treatment:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2016,101(5):1889-1916.DOI:10.1210/jc.2015-4061. [41]MILLIEZ P,GIRERD X,PLOUIN P F,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45(8):1243-1248.DOI:10.1016/j.jacc.2005.01.015. [42]FOURKIOTIS V,VONEND O,DIEDERICH S,et al.Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism[J].Eur J Endocrinol,2013,168(1):75-81.DOI:10.1530/eje-12-0631. [43]SUNDSTROM J,NEOVIUS M,TYNELIUS P,et al.Association of blood pressure in late adolescence with subsequent mortality:cohort study of Swedish male conscripts[J].BMJ,2011,342:d643.DOI:10.1136/bmj.d643. [44]VIERA A J,ZHU S,HINDERLITER A L,et al.Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults:the CARDIA study[J].J Am Soc Hypertens,2011,5(1):48-55.DOI:10.1016/j.jash.2010.12.002. [45]ZHANG Y,MORAN A E.Trends in the prevalence,awareness,treatment,and control of hypertension among young adults in the United States,1999 to 2014[J].Hypertension,2017,70(4):736-742.DOI:10.1161/hypertensionaha.117.09801. [46]陈诗颖,吴逸海,林少炜,等.福建省沿海地区城镇青年高血压流行现状及其影响因素[J].中华高血压杂志,2015,23(11):1080-1083.DOI:10.16439/j.cnki.1673-7245.2015.11.029. CHEN S Y,WU Y H,LIN S W,et al.Prevalence of hypertension among urban youth in coastal areas of Fujian Province and its influencing factors[J].Chinese Journal of Hypertension,2015,23(11):1080-1083.DOI:10.16439/j.cnki.1673-7245.2015.11.029. |
[1] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[2] | CHEN Ai, SUN Lina, REN Jiaqi, CHANG Chun, CHEN Yahong, SUN Yongchang. Prevalence and Clinical Characteristics of Allergic Bronchopulmonary Aspergillosis in Patients with Bronchiectasis [J]. Chinese General Practice, 2023, 26(30): 3797-3800. |
[3] | XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709. |
[4] | CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488. |
[5] | BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391. |
[6] | ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049. |
[7] | ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777. |
[8] | FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580. |
[9] | YU Tong, YANG Yi, DU Shihong, DING Zihao, HONG Xiuqin. Correlation of Shearing Force and Estradiol with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2469-2475,2495. |
[10] | FEI Min, LEI Si, XU Yan, YE Yun, ZHUO Hui, ZHANG Hui, LUO Yingquan. Association of Obstructive Sleep Apnea-hypopnea Syndrome with Blood Pressure Variability and Heart Rate Variability in Patients with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2459-2468. |
[11] | TIAN Meixiang, ZHANG Zhengyi. Standard Management of Hypertension During the Preparation for Pregnancy [J]. Chinese General Practice, 2023, 26(18): 2190-2194. |
[12] | LIU Hai, HUANG Guanhua. The Significance of High Normal Blood Pressure for Children and Adolescents [J]. Chinese General Practice, 2023, 26(18): 2183-2189. |
[13] | LIU Rongmei, MAO Yanna, LIU Gendang, ZHAO Yukun, YU Mingyang, ZHAO Qiuping. Number and Costs of Hospitalizations Due to Hypertension and Related Comorbidities and Complications in County-level Healthcare Institutions in a Poverty-stricken County in Henan from 2017 to 2019 [J]. Chinese General Practice, 2023, 26(16): 2020-2026,2035. |
[14] | ZHANG Shuo, FU Yingjie, CHANG Lele, SUN Xiaojie. Qualitative Study of Health Management for Hypertensive Patients in Shandong's Rural Areas Using the Innovative Care for Chronic Conditions Framework [J]. Chinese General Practice, 2023, 26(16): 1972-1978,1983. |
[15] | YUE Bocheng, HOU Qiqi, HAN Quanle, YANG Bo, WU Zheng, WU Jianmei, CHEN Shuohua, WU Shouling, LI Kangbo. Effect of Atrial Fibrillation on the Risk of New-onset Myocardial Infarction in Hypertensive Population [J]. Chinese General Practice, 2023, 26(14): 1739-1744. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||